Diabetes Care Devices - Norway | Statista Market Forecast

Revenue in the Diabetes Care Devices market market in Norway is anticipated to hit US$160.20m in 2024.
This revenue is predicted to experience an annual growth rate (CAGR 2024-2029) of 10.57%, leading to a market volume of US$264.80m by 2029.
In comparison to global figures, the majority of revenue in this sector will be produced the United States, amounting to US$11.71bn in 2024.
Norway is witnessing a significant shift towards advanced diabetes care devices, driven by increasing government support and rising patient awareness of innovative treatment options.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market in Norway is witnessing considerable growth, fueled by advancements in technology, increasing prevalence of diabetes, and heightened awareness of self-management among patients, enhancing the demand for innovative care solutions.

Customer preferences: Consumers in Norway are increasingly prioritizing personalized diabetes management solutions, driven by a growing understanding of their health needs and preferences. There is a marked shift towards integrating technology with daily routines, as individuals seek smart diabetes care devices that offer real-time monitoring and data analytics. Furthermore, the rise of health-conscious younger demographics is fostering demand for user-friendly applications that facilitate seamless communication with healthcare providers. This trend is accentuated by a cultural emphasis on proactive health management and community support.

Trends in the market: In Norway, the Diabetes Care Devices Market is experiencing a significant shift towards innovative, user-centric solutions that enhance personalized diabetes management. Healthcare providers are increasingly integrating wearable technology and mobile applications to enable real-time glucose monitoring and data sharing, fostering a collaborative approach between patients and healthcare professionals. The emphasis on preventative health is driving demand for devices that not only track metrics but also offer actionable insights. This trend is crucial for stakeholders, as it opens avenues for investment in advanced technology and promotes partnerships that prioritize patient engagement and support.

Local special circumstances: In Norway, the Diabetes Care Devices Market is uniquely influenced by the country’s strong emphasis on public health and preventive care. The Norwegian healthcare system prioritizes accessibility and equity, ensuring that diabetes management tools are available to all citizens, including remote populations. Additionally, cultural attitudes towards technology adoption are favorable, with a high acceptance of digital health solutions. Regulatory frameworks support innovation, allowing faster approvals for advanced diabetes technologies, thus fostering a collaborative ecosystem among manufacturers, healthcare providers, and patients.

Underlying macroeconomic factors: The Diabetes Care Devices Market in Norway is shaped by several macroeconomic factors, including national economic health, demographic trends, and public investment in healthcare. A robust economy supports increased healthcare spending, enabling the adoption of advanced diabetes management technologies. Norway’s aging population and rising incidence of diabetes further amplify the demand for innovative devices. Additionally, favorable fiscal policies promote research and development in medical technology, while a strong social welfare system ensures equitable access to these devices. Global economic trends, such as the push for digital health solutions, also enhance market dynamics, fostering a collaborative environment among stakeholders.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.